Visual storytelling for medical publications
2022-08-12 10:37
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS
@mdwrtcom
In low-risk
#MDS
patients use of lower hypomethylating agents’ doses was still associated with clinical efficacy, meaning more benefit and less dose-limiting toxicity
https://bit.ly/3p76XRN
#VisualAbstract
#in
#hematology
@mdwrtcom